Goodwin-Led Cancer Drug Co. Prices Upsized $201M IPO
A team of lawyers from Goodwin Procter LLP represented cancer drug company Black Diamond Therapeutics Inc. in the pricing of its $201 million initial public offering, a range revised upward by...To view the full article, register now.
Already a subscriber? Click here to view full article